See more : Talon 1 Acquisition Corp. (TOAC) Income Statement Analysis – Financial Results
Complete financial analysis of ISE Chemicals Corporation (ICHMF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ISE Chemicals Corporation, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Seiko PMC Corporation (4963.T) Income Statement Analysis – Financial Results
- i-Tail Corporation Public Company Limited (ITC.BK) Income Statement Analysis – Financial Results
- Odontoprev S.A. (ODPV3.SA) Income Statement Analysis – Financial Results
- Tamar Petroleum Ltd (TMRP.TA) Income Statement Analysis – Financial Results
- XY Labs, Inc. (XYLB) Income Statement Analysis – Financial Results
ISE Chemicals Corporation (ICHMF)
About ISE Chemicals Corporation
ISE Chemicals Corporation engages in the production, processing, and trade of iodine and iodine derivatives, and nickel and cobalt compounds in Japan. The company offers iodine for use in X-ray contrast media, polarizing films, disinfectants, catalysts, stabilizers, pharmaceuticals, sodium additives, feed additives, and other applications; and cobalt and nickel compounds for use in electronic components. It also extracts and supplies natural gas to gas companies and factories. The company was founded in 1927 and is headquartered in Tokyo, Japan. ISE Chemicals Corporation is a subsidiary of AGC Inc.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 26.41B | 25.56B | 20.35B | 16.86B | 16.85B |
| Cost of Revenue | 19.03B | 19.89B | 15.91B | 13.07B | 13.23B |
| Gross Profit | 7.39B | 5.67B | 4.45B | 3.79B | 3.62B |
| Gross Profit Ratio | 27.96% | 22.19% | 21.85% | 22.46% | 21.50% |
| Research & Development | 260.00M | 260.00M | 264.00M | 248.00M | 224.00M |
| General & Administrative | 1.49B | 1.42B | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 302.00M | 206.00M | 0.00 | 0.00 | 0.00 |
| SG&A | 1.79B | 1.62B | 1.44B | 1.32B | 1.34B |
| Other Expenses | 41.00M | 1.00M | 1.00M | 1.00M | 0.00 |
| Operating Expenses | 2.09B | 1.92B | 1.74B | 1.60B | 1.57B |
| Cost & Expenses | 21.12B | 21.81B | 17.64B | 14.67B | 14.80B |
| Interest Income | 5.00M | 3.00M | 6.00M | 10.00M | 8.00M |
| Interest Expense | 1.00M | 1.00M | 1.00M | 1.00M | 1.00M |
| Depreciation & Amortization | 1.97B | 1.81B | 1.49B | 1.31B | 1.36B |
| EBITDA | 7.17B | 5.57B | 4.20B | 3.50B | 3.41B |
| EBITDA Ratio | 27.15% | 21.39% | 20.53% | 20.46% | 20.26% |
| Operating Income | 5.30B | 3.76B | 2.71B | 2.19B | 2.06B |
| Operating Income Ratio | 20.05% | 14.69% | 13.31% | 12.96% | 12.21% |
| Total Other Income/Expenses | -96.00M | -157.00M | -117.00M | -196.00M | -246.00M |
| Income Before Tax | 5.20B | 3.60B | 2.59B | 1.99B | 1.81B |
| Income Before Tax Ratio | 19.69% | 14.08% | 12.73% | 11.80% | 10.75% |
| Income Tax Expense | 1.53B | 1.04B | 818.00M | 645.00M | 621.00M |
| Net Income | 3.67B | 2.56B | 1.77B | 1.34B | 1.19B |
| Net Income Ratio | 13.90% | 10.02% | 8.71% | 7.97% | 7.07% |
| EPS | 7.20 | 5.03 | 3.48 | 2.64 | 2.34 |
| EPS Diluted | 7.20 | 5.03 | 3.48 | 2.64 | 2.34 |
| Weighted Avg Shares Out | 509.70M | 509.80M | 509.80M | 509.90M | 509.90M |
| Weighted Avg Shares Out (Dil) | 509.70M | 509.80M | 509.80M | 509.90M | 509.90M |
Source: https://incomestatements.info
Category: Stock Reports